BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25895667)

  • 21. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
    Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute myeloid leukemia with t(11;22) (q23;q11.2): two cases report and literature review].
    Wang T; Gao W; Liu HX; Teng W; Ren J; Wang CF; Zhang Y; Cao W; Wang H; Tong CR
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1028-31. PubMed ID: 24369159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.
    Qian SX; Li JY; Tian T; Shen YF; Jiang YQ; Lu H; Wu HX; Zhang SJ; Xu W
    Leuk Res; 2007 Oct; 31(10):1383-8. PubMed ID: 17420048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia.
    Lim SW; Falk RE; Look RM; Fuerst MM; Lawrence GN; Kusuanco DA; Giles FJ
    Cancer Genet Cytogenet; 1996 Feb; 86(2):165-7. PubMed ID: 8603347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality].
    Calderón-Cabrera C; Falantes JF; Bernal R; Pérez-Simón JA
    Med Clin (Barc); 2015 Sep; 145(5):224-6. PubMed ID: 25190583
    [No Abstract]   [Full Text] [Related]  

  • 26. Complex t(8;14;21)(q22;q13;q22), a variant of t(8;21), with t(15;21)(q15;p11) in a patient with acute myelogenous leukemia (M1).
    Takahashi T; Maruyama Y; Satoh Y; Yoshimoto M; Tsujisaki M
    Cancer Genet Cytogenet; 2004 Dec; 155(2):152-3. PubMed ID: 15571802
    [No Abstract]   [Full Text] [Related]  

  • 27. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
    Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
    Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
    Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
    Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Liu L; Jiao W; Zhang Y; Qu Q; Li X; Wu D
    Leuk Res; 2015 Mar; 39(3):323-8. PubMed ID: 25638269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia.
    Suzushima H; Wada N; Yamasaki H; Eto K; Shimomura T; Kugimiya MH; Horikawa K; Nishimura S; Tsuda H; Mitsuya H; Asou N
    Leuk Res; 2010 May; 34(5):610-4. PubMed ID: 19744710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
    Scholl C; Schlenk RF; Eiwen K; Döhner H; Fröhling S; Döhner K;
    Haematologica; 2005 Dec; 90(12):1626-34. PubMed ID: 16330435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
    Fukushima T; Kawabata H; Sawaki T; Satoh T; Nakamura T; Iwao H; Nakajima A; Sakai T; Miki M; Fujita Y; Tanaka M; Kawanami T; Masaki Y; Okazaki T; Umehara H
    Anticancer Res; 2012 Apr; 32(4):1347-53. PubMed ID: 22493369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Translocation t (7; 11) (p15; p15) in acute myelomonocytic leukemia].
    Niikura H; Takizawa Y; Okada S; Hagiwara S; Mori H; Terada H; Fujita K; Shinohara T
    Rinsho Ketsueki; 1988 Jan; 29(1):48-53. PubMed ID: 3164417
    [No Abstract]   [Full Text] [Related]  

  • 34. H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia.
    Han Q; Lu J; Wang J; Ye J; Jiang X; Chen H; Liu C; Chen L; Lin T; Chen S; Sun M; Gao F
    Cancer Genet; 2018 Apr; 222-223():9-12. PubMed ID: 29666008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome.
    Glassman AB; Hayes KJ
    Ann Clin Lab Sci; 2003; 33(3):285-8. PubMed ID: 12956443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous presence of t(10;11)(p12;q23) and t(11;19)(q23;p13.1) in an infantile acute myeloid leukemia.
    Wu SQ; Lu G; Chen XR; Quinn J
    Cancer Genet Cytogenet; 2006 Jul; 168(2):175-6. PubMed ID: 16843111
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of Curative Effects of HAG and CAG Regimens for Patients with AML and Medium/High-Risk MDS].
    Zhu YN; Yang XF; Wang DZ; Liu ZW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):698-701. PubMed ID: 27342493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage therapy with decitabine in combination with granulocyte colony-stimulating factor, low-dose cytarabine, and aclarubicin in patients with refractory or relapsed early T-cell precursor acute lymphoblastic leukemia.
    Meng T; Yao Y; Xu Y; Xue S; Han Y; Tang X; Qiu H; Sun A; Wu D; Zhang Y; Wang Y
    Hematol Oncol; 2020 Dec; 38(5):834-837. PubMed ID: 32710795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
    Yamamoto K; Nagata K; Morita Y; Hamaguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CASP8AP2 is a novel partner gene of MLL rearrangement with t(6;11)(q15;q23) in acute myeloid leukemia.
    Park TS; Lee SG; Song J; Lee KA; Kim J; Choi JR; Lee ST; Marschalek R; Meyer C
    Cancer Genet Cytogenet; 2009 Nov; 195(1):94-5. PubMed ID: 19837277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.